BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8610635)

  • 1. Ifosfamide and cisplatin as neoadjuvant chemotherapy for advanced cervical carcinoma.
    Leone B; Vallejo C; Perez J; Cuevas MA; Machiavelli M; Lacava J; Focaccia G; Ferreyra R; Suttora G; Romero A; Castaldi J; Arroyo A; Rabinovich M
    Am J Clin Oncol; 1996 Apr; 19(2):132-5. PubMed ID: 8610635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy with ifosfamide, cisplatin, and vinorelbine in advanced squamous cell carcinoma of the cervix.
    Vallejo CT; Pérez JE; Domínguez ME; Leone BA; Machiavelli MR; Lacava JA; Romero AO; Ortiz EH; Grasso S; Amato S; Rodríguez R; Barbieri M; Romero Acuña J; Focaccia G; Suttora G; Scenna M; Boughen JM; Romero Acuña LA; Langhi MJ
    Am J Clin Oncol; 2000 Oct; 23(5):481-6. PubMed ID: 11039508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma.
    Scandurra G; Scibilia G; Banna GL; D'Agate G; Lipari H; Gieri S; Scollo P
    J Gynecol Oncol; 2015 Apr; 26(2):118-24. PubMed ID: 25686397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
    Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
    Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung carcinoma.
    Vallejo C; Romero A; Perez J; Cuevas M; Lacava J; Sabatini C; Dominguez M; Rodriguez R; Barbieri M; Romero Acuña L; Romero Acuña J; Langhi M; Amato S; Salvadori M; Ortiz E; Machiavelli M; Leone B
    Am J Clin Oncol; 1996 Dec; 19(6):584-8. PubMed ID: 8931677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of ifosfamide and systemic therapy in the management of carcinoma of the cervix.
    Thigpen T; Vance R; Khansur T; Malamud F
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):56-64. PubMed ID: 8677451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer.
    Zanetta G; Lissoni A; Pellegrino A; Sessa C; Colombo N; Gueli-Alletti D; Mangioni C
    Ann Oncol; 1998 Sep; 9(9):977-80. PubMed ID: 9818071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of ifosfamide and cisplatinum in advanced ovarian cancer.
    Aziz Z; Zahid M; Ud Din Ahmed Z; Arshad T
    Aust N Z J Med; 1998 Jun; 28(3):403-9. PubMed ID: 9673759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
    Buxton EJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-ifosfamide as neoadjuvant chemotherapy in stage IIIB cervical uterine squamous-cell carcinoma.
    Lara PC; Garcia-Puche JL; Pedraza V
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S36-8. PubMed ID: 2347047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.
    Mantovani G; Ghiani M; Lai P; Maccio A; Dessi D; Succu G; Massa D; Curreli L; Mulas C; Esu S; Proto E; Cadeddu G; Tore G
    Oncol Rep; 1998; 5(6):1499-505. PubMed ID: 9769395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Outcome of Neoadjuvant Radiochemotherapy in Locally Advanced Cervical Cancer: Results of an Open Prospective, Multicenter Phase 2 Study of the North-Eastern German Society of Gynecological Oncology.
    Koensgen D; Sehouli J; Belau A; Weiss M; Stope MB; Grokopf V; Eichbaum M; Ledwon P; Lichtenegger W; Zygmunt M; Köhler G; Mustea A
    Int J Gynecol Cancer; 2017 Mar; 27(3):500-506. PubMed ID: 28187089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G; Fei F; Mangioni C
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy for cervical carcinoma.
    Rabinovich MG; Focaccia G; Ferreyra R; Elem Y; Leone BA; Vallejo CT
    Obstet Gynecol; 1991 Oct; 78(4):685-8. PubMed ID: 1717907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoposide (VP-16), ifosfamide/mesna, and cisplatin chemotherapy for advanced and recurrent carcinoma of the cervix.
    Kredentser DC
    Gynecol Oncol; 1991 Nov; 43(2):145-8. PubMed ID: 1743556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II trial of four courses of preoperative chemotherapy in squamous or anaplastic carcinoma of the oesophagus.
    Steyn RS; Darnton SJ; McManus KG; McAleer JA; Cullen MH; Matthews HR
    Clin Oncol (R Coll Radiol); 1998; 10(3):165-9. PubMed ID: 9704178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix.
    Tabata T; Nishiura K; Yanoh K; Okugawa T; Obata H; Tanaka K; Toyoda N
    Int J Clin Oncol; 2004 Feb; 9(1):59-63. PubMed ID: 15162828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix. A phase II trial.
    Cervellino JC; Araujo CE; Sánchez O; Miles H; Nishihama A
    Acta Oncol; 1995; 34(2):257-9. PubMed ID: 7718266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
    Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
    Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
    Omura GA; Blessing JA; Vaccarello L; Berman ML; Clarke-Pearson DL; Mutch DG; Anderson B
    J Clin Oncol; 1997 Jan; 15(1):165-71. PubMed ID: 8996138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.